OSAKA, Japan & SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Santen Pharmaceutical Co., Ltd. (“Santen” TSE: 4536) and Glaukos Corporation (“Glaukos” NYSE: GKOS), announced today that Santen’s U.S. subsidiary, Santen Inc., has entered into a multi-year agr…
Uncategorized
CTR-blocked angle increases IOP in chronic hypotony
Patients who underwent a novel surgical method to treat chronic ocular hypotony experienced increased IOP and visual acuity through a mean 27.7-month follow-up period, according to a study.The retrospective case series describes a surgical method that …
Alcon to Participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
GENEVA–(BUSINESS WIRE)–Alcon to participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
Alcon to Participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
GENEVA–(BUSINESS WIRE)–Alcon to participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences
Uncategorized
Aerie aims multi-kinase inhibitor at retinal disease
The FDA has accepted Aerie Pharmaceuticals’ investigational new drug application for the AR-13503 implant, the company’s treatment candidate for neovascular age-related macular degeneration and diabetic macular edema, the company announced in a press r…
Physicianeer Derek O’Keefe on The Future of Medicine Powered by Wearable Devices
While some people talk about the future of medicine, others actually live in it. Dr. Derek O’Keefe calls himself a physicianeer, which is a combination doctor/engineer, and he’s been working with NASA to help the agency better monitor its astronauts and to provide treatment at a distance. Through his experiences, Dr. O’Keefe has s (Read more...)